Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Cipla
Medtronic
Fuji
Farmers Insurance

Generated: May 21, 2019

DrugPatentWatch Database Preview

Iopromide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iopromide and what is the scope of iopromide patent protection?

Iopromide is the generic ingredient in six branded drugs marketed by Bayer Hlthcare and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for iopromide. One supplier is listed for this compound.

Pharmacology for iopromide
Synonyms for iopromide
1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamide
1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methyl-
1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((methoxyacetyl)amino)-N-methyl-2,4,6-triiodo-
334I073
712BAC33MZ
73334-07-3
AB00513942
AC-535
AC1L1GLH
AC1Q4PC5
AKOS025402129
AN-15741
BAY 86-4877
BAY86-4877
BC200690
BCP08449
BPBio1_001039
BRN 7085608
BSPBio_000943
C-23779
C18H24I3N3O8
CAS-73334-07-3
CC-29577
CCG-220872
CHEBI:63578
CHEMBL1725
CS-0013103
D01893
DB09156
DGAIEPBNLOQYER-UHFFFAOYSA-N
DSSTox_CID_3163
DSSTox_GSID_23163
DSSTox_RID_76898
DTXSID0023163
EINECS 277-385-9
FT-0627283
HMS1570P05
HMS2097P05
HMS2233O23
HMS3370M05
HMS3714P05
HY-B1362
I661
iopromid
Iopromida
Iopromida [INN-Spanish]
Iopromide (JAN/USP/INN)
Iopromide [USAN:INN:BAN]
Iopromide [USAN:USP:INN:BAN]
Iopromide for system suitability 1, European Pharmacopoeia (EP) Reference Standard
Iopromide for system suitability 2, European Pharmacopoeia (EP) Reference Standard
Iopromide, analytical standard
Iopromide, European Pharmacopoeia (EP) Reference Standard
Iopromide, United States Pharmacopeia (USP) Reference Standard
Iopromidum
Iopromidum [INN-Latin]
LS-29729
MLS002154045
MolPort-005-932-395
N-(2,3-dihydroxypropyl)-3-[(2,3-dihydroxypropyl)(methyl)carbamoyl]-5-[(1-hydroxy-2-methoxyethylidene)amino]-2,4,6-triiodobenzene-1-carboximidic acid
N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide
N,N'-Bis(2,3-Dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-1,3-benzenedicarboxamide
n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-n-methylisophthalamide
N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-5-{[(methyloxy)acetyl]amino}benzene-1,3-dicarboxamide
N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N1-methylisophthalamide
N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
NCGC00016923-01
NCGC00179367-01
NCGC00179367-03
Prestwick0_000872
Prestwick1_000872
Prestwick2_000872
Prestwick3_000872
Proscope (TN)
SCHEMBL24546
SHL 414C
SMR001233368
SPBio_002864
SR-01000841262
SR-01000841262-2
Tox21_110684
Tox21_110684_1
Ultravist
Ultravist (pharmacy bulk)
Ultravist (TN)
Ultravist 150
Ultravist 240
Ultravist 300
Ultravist 300 In Plastic Container
Ultravist 370
UNII-712BAC33MZ
ZK 35760
ZK-35760

US Patents and Regulatory Information for iopromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-002 Sep 20, 2002 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-003 Mar 12, 2004 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST 150 iopromide INJECTABLE;INJECTION 020220-004 May 10, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST 300 IN PLASTIC CONTAINER iopromide INJECTABLE;INJECTION 020220-005 Nov 18, 2008 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for iopromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare ULTRAVIST 370 iopromide INJECTABLE;INJECTION 020220-001 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-002 Sep 20, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-003 Mar 12, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST 300 iopromide INJECTABLE;INJECTION 020220-002 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Harvard Business School
Daiichi Sankyo
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.